Cigalah Group agreed to acquire 51% stake in Alpha Pharma L.L.C. from Gulf Pharmaceutical Industries P.S.C. (ADX:JULPHAR) on June 16, 2021. Transaction is subject to antitrust approval General Authority for Competition in the Kingdom of Saudi Arabia which was received during the current period. The transaction is expected to complete in third quarter of 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.941 AED | -0.11% | -1.98% | +22.37% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+22.37% | 296M | |
+4.06% | 70.44B | |
+10.97% | 8.94B | |
-14.44% | 4.75B | |
+41.60% | 4.5B | |
+5.96% | 3.85B | |
+23.46% | 2.38B | |
-19.32% | 2.34B | |
-27.04% | 2.2B | |
+7.97% | 1.96B |
- Stock Market
- Equities
- JULPHAR Stock
- News Gulf Pharmaceutical Industries
- Cigalah Group agreed to acquire 51% stake in Alpha Pharma L.L.C. from Gulf Pharmaceutical Industries P.S.C..